Center for Drug Evaluation and Research (U.S.) & Center for Biologics Evaluation and Research (U.S.). (2004). Guidance for industry: IND exemptions for studies of lawfully marketed drug or biological products for the treatment of cancer. U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research.
Chicago Style (17th ed.) CitationCenter for Drug Evaluation and Research (U.S.) and Center for Biologics Evaluation and Research (U.S.). Guidance for Industry: IND Exemptions for Studies of Lawfully Marketed Drug or Biological Products for the Treatment of Cancer. Rockville, MD: U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, 2004.
MLA (9th ed.) CitationCenter for Drug Evaluation and Research (U.S.) and Center for Biologics Evaluation and Research (U.S.). Guidance for Industry: IND Exemptions for Studies of Lawfully Marketed Drug or Biological Products for the Treatment of Cancer. U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, 2004.